Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity

European Journal of Immunology

Volumn 30, Issue 11, 2000, Pages 3309-3318

  Nakajima, Hideo ^a,c   Cella, Marina ^a   Bouchon, Axel ^a   Grierson, Helen L ^a   Lewis, Jennifer ^b   Duckett, Colin S ^b   Cohen, Jeffrey I ^b   Colonna, Marco ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Epstein Barr virus; Human; NK; SLAM associated protein; X linked lymphoproliferative

Indexed keywords

ARTICLE; BONE MARROW CELL; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; X CHROMOSOME LINKED DISORDER;

ANTIGENS, CD; CARRIER PROTEINS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0033729573     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3     Document Type: Article

References (43)

1. X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology
2. Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndrome
3. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects
4. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome
5. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
6. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
7. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
8. A novel receptor involved in T-cell activation
9. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production
10. SLAM and its role in T cell activation and Th cell responses
11. Cutting edge: Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP- 2 and the adaptor signaling protein SAP
12. Activating interactions in human NK cell recognition: The role of 2B4- CD 48
13. Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4
14. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD 48
15. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells
16. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer ceils and T cells
17. 2B4, a new member of the immunoglobulin gene superfamily, is expressed on murine dendritic epidermal T cells and plays a functional role in their killing of skin tumors
18. Activation of murine epidermal gamma delta T cells through surface 2B4
19. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
20. Identification of the 2B4 molecule as a counter-receptor for CD 48
21. 2B4 functions as a co-receptor in human NK cell activation
22. + T cells
23. Faces and phases of human CD8 T-cell development
24. Gene structure of the murine NK cell receptor 2B4: Presence of two alternatively spliced isoforms with distinct cytoplasmic domains
25. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4
26. Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules
27. Expression of lineage-restricted protein tyrosine kinase genes in human natural killer cells
28. Association of the p56lck protein tyrosine kinase with the Fc gamma RIIIA/CD16 complex in human natural killer cells
29. Physical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells
30. Interaction between lck and syk family tyrosine kinases in Fc gamma receptor-initiated activation of natural killer cells
31. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation
32. Association of human NK cell surface receptors NKR-P1 and CD94 with Src- family protein kinases
33. Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor
34. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48
35. Vaccine strategies against Epstein-Barr virus-associated diseases: Lessons from studies on cytotoxic T-cell-mediated immune regulation
36. The biology of Epstein-Barr virus: Lessons learned from the virus and the host
37. CD84 leukocyte antigen is a new member of the lg superfamily
38. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition
39. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells)
40. Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes
41. Cooperation between Syk and Rac 1 leads to synergistic JNK activation in T lymphocytes
42. Functional requirement for SLAM-associated protein in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome
43. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells